

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 9.67737975 |
| 2 | primary alcohol catabolic process (GO:0034310) | 7.63913644 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 6.81626501 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.81626501 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 6.51735198 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.51735198 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.05512256 |
| 8 | alkaloid metabolic process (GO:0009820) | 5.88908132 |
| 9 | glycoside metabolic process (GO:0016137) | 5.88780229 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.67903651 |
| 11 | alpha-linolenic acid metabolic process (GO:0036109) | 5.58431001 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.48579463 |
| 13 | kynurenine metabolic process (GO:0070189) | 5.42422037 |
| 14 | tryptophan catabolic process (GO:0006569) | 5.41325184 |
| 15 | indole-containing compound catabolic process (GO:0042436) | 5.41325184 |
| 16 | indolalkylamine catabolic process (GO:0046218) | 5.41325184 |
| 17 | glyoxylate metabolic process (GO:0046487) | 5.15645424 |
| 18 | cysteine metabolic process (GO:0006534) | 5.12518901 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 5.11578871 |
| 20 | complement activation, alternative pathway (GO:0006957) | 5.10640268 |
| 21 | sulfur amino acid catabolic process (GO:0000098) | 5.10080619 |
| 22 | tyrosine metabolic process (GO:0006570) | 5.09422941 |
| 23 | tryptophan metabolic process (GO:0006568) | 5.08244621 |
| 24 | urea cycle (GO:0000050) | 5.08058103 |
| 25 | urea metabolic process (GO:0019627) | 5.08058103 |
| 26 | regulation of protein activation cascade (GO:2000257) | 5.04018634 |
| 27 | high-density lipoprotein particle remodeling (GO:0034375) | 5.01628862 |
| 28 | protein carboxylation (GO:0018214) | 4.83863468 |
| 29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.83863468 |
| 30 | regulation of fibrinolysis (GO:0051917) | 4.79860799 |
| 31 | regulation of complement activation (GO:0030449) | 4.77590650 |
| 32 | bile acid metabolic process (GO:0008206) | 4.70930464 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 4.68830975 |
| 34 | aromatic amino acid family metabolic process (GO:0009072) | 4.63722337 |
| 35 | bile acid and bile salt transport (GO:0015721) | 4.61707772 |
| 36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.60733762 |
| 37 | * ethanol oxidation (GO:0006069) | 4.59004877 |
| 38 | progesterone metabolic process (GO:0042448) | 4.52231281 |
| 39 | benzene-containing compound metabolic process (GO:0042537) | 4.50417743 |
| 40 | reverse cholesterol transport (GO:0043691) | 4.48359239 |
| 41 | homocysteine metabolic process (GO:0050667) | 4.47669913 |
| 42 | indolalkylamine metabolic process (GO:0006586) | 4.42137246 |
| 43 | serine family amino acid catabolic process (GO:0009071) | 4.39836342 |
| 44 | phenylpropanoid metabolic process (GO:0009698) | 4.39594248 |
| 45 | coenzyme catabolic process (GO:0009109) | 4.32208680 |
| 46 | amino-acid betaine metabolic process (GO:0006577) | 4.31730371 |
| 47 | regulation of triglyceride catabolic process (GO:0010896) | 4.31184005 |
| 48 | plasma lipoprotein particle remodeling (GO:0034369) | 4.27571529 |
| 49 | protein-lipid complex remodeling (GO:0034368) | 4.27571529 |
| 50 | macromolecular complex remodeling (GO:0034367) | 4.27571529 |
| 51 | regulation of cholesterol esterification (GO:0010872) | 4.26952210 |
| 52 | lysine metabolic process (GO:0006553) | 4.24239773 |
| 53 | lysine catabolic process (GO:0006554) | 4.24239773 |
| 54 | cellular ketone body metabolic process (GO:0046950) | 4.22457004 |
| 55 | dopamine transport (GO:0015872) | 4.16081587 |
| 56 | triglyceride homeostasis (GO:0070328) | 4.15327426 |
| 57 | acylglycerol homeostasis (GO:0055090) | 4.15327426 |
| 58 | alpha-amino acid catabolic process (GO:1901606) | 4.13712681 |
| 59 | negative regulation of sterol transport (GO:0032372) | 4.02870828 |
| 60 | negative regulation of cholesterol transport (GO:0032375) | 4.02870828 |
| 61 | glutamate metabolic process (GO:0006536) | 4.01581826 |
| 62 | phospholipid efflux (GO:0033700) | 3.99993005 |
| 63 | plasma lipoprotein particle clearance (GO:0034381) | 3.90264555 |
| 64 | cellular glucuronidation (GO:0052695) | 3.89720417 |
| 65 | aldehyde catabolic process (GO:0046185) | 3.88000393 |
| 66 | cellular amino acid catabolic process (GO:0009063) | 3.87456775 |
| 67 | cholesterol efflux (GO:0033344) | 3.87175609 |
| 68 | macroautophagy (GO:0016236) | 3.84774447 |
| 69 | drug catabolic process (GO:0042737) | 3.76190933 |
| 70 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.74966808 |
| 71 | axonemal dynein complex assembly (GO:0070286) | 3.70157890 |
| 72 | cellular biogenic amine catabolic process (GO:0042402) | 3.69086485 |
| 73 | amine catabolic process (GO:0009310) | 3.69086485 |
| 74 | response to nitrosative stress (GO:0051409) | 3.67902664 |
| 75 | cellular modified amino acid catabolic process (GO:0042219) | 3.67685451 |
| 76 | toxin transport (GO:1901998) | 3.66629300 |
| 77 | imidazole-containing compound metabolic process (GO:0052803) | 3.65181601 |
| 78 | ketone body metabolic process (GO:1902224) | 3.64395011 |
| 79 | quinone metabolic process (GO:1901661) | 3.62558217 |
| 80 | glycine metabolic process (GO:0006544) | 3.61838729 |
| 81 | epoxygenase P450 pathway (GO:0019373) | 3.59354141 |
| 82 | flavonoid metabolic process (GO:0009812) | 3.58435917 |
| 83 | * primary alcohol metabolic process (GO:0034308) | 3.56385851 |
| 84 | C21-steroid hormone metabolic process (GO:0008207) | 3.56173579 |
| 85 | serine family amino acid metabolic process (GO:0009069) | 3.56154994 |
| 86 | phospholipid homeostasis (GO:0055091) | 3.55798847 |
| 87 | complement activation, classical pathway (GO:0006958) | 3.55737498 |
| 88 | short-chain fatty acid metabolic process (GO:0046459) | 3.54191402 |
| 89 | uronic acid metabolic process (GO:0006063) | 3.53617819 |
| 90 | glucuronate metabolic process (GO:0019585) | 3.53617819 |
| 91 | arginine metabolic process (GO:0006525) | 3.51793661 |
| 92 | plasma lipoprotein particle assembly (GO:0034377) | 3.51441155 |
| 93 | fibrinolysis (GO:0042730) | 3.51307942 |
| 94 | low-density lipoprotein particle remodeling (GO:0034374) | 3.51239756 |
| 95 | cofactor catabolic process (GO:0051187) | 3.50160374 |
| 96 | negative regulation of lipase activity (GO:0060192) | 3.49807574 |
| 97 | complement activation (GO:0006956) | 3.49257632 |
| 98 | cytolysis (GO:0019835) | 3.47690199 |
| 99 | dopamine biosynthetic process (GO:0042416) | 3.47370225 |
| 100 | regulation of cholesterol homeostasis (GO:2000188) | 3.46759702 |
| 101 | positive regulation of lipid catabolic process (GO:0050996) | 3.46196269 |
| 102 | drug transmembrane transport (GO:0006855) | 3.46002254 |
| 103 | organic acid catabolic process (GO:0016054) | 3.45735828 |
| 104 | carboxylic acid catabolic process (GO:0046395) | 3.45735828 |
| 105 | retinal metabolic process (GO:0042574) | 3.43487170 |
| 106 | acetyl-CoA metabolic process (GO:0006084) | 3.42613627 |
| 107 | exogenous drug catabolic process (GO:0042738) | 3.42514016 |
| 108 | cholesterol homeostasis (GO:0042632) | 3.40820577 |
| 109 | negative regulation of protein activation cascade (GO:2000258) | 3.39285056 |
| 110 | vitamin D metabolic process (GO:0042359) | 3.39035938 |
| 111 | secondary metabolic process (GO:0019748) | 3.38272652 |
| 112 | protein activation cascade (GO:0072376) | 3.38265073 |
| 113 | opsonization (GO:0008228) | 3.37137008 |
| 114 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.36350426 |
| 115 | sterol homeostasis (GO:0055092) | 3.36050530 |
| 116 | * ethanol metabolic process (GO:0006067) | 3.35847233 |
| 117 | regulation of extracellular matrix disassembly (GO:0010715) | 3.34197901 |
| 118 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.33442014 |
| 119 | negative regulation of hormone metabolic process (GO:0032351) | 3.31593396 |
| 120 | negative regulation of complement activation (GO:0045916) | 3.22518815 |
| 121 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.21353376 |
| 122 | cellular response to vitamin D (GO:0071305) | 3.19731079 |
| 123 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.12203905 |
| 124 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.11741567 |
| 125 | cilium movement (GO:0003341) | 3.09675050 |
| 126 | intestinal cholesterol absorption (GO:0030299) | 3.07182058 |
| 127 | alcohol catabolic process (GO:0046164) | 3.06623986 |
| 128 | negative regulation of humoral immune response (GO:0002921) | 3.06362335 |
| 129 | peptide hormone processing (GO:0016486) | 3.03876656 |
| 130 | retinoic acid metabolic process (GO:0042573) | 3.01076641 |
| 131 | * cellular aldehyde metabolic process (GO:0006081) | 2.99277602 |
| 132 | drug metabolic process (GO:0017144) | 2.97691509 |
| 133 | insulin secretion (GO:0030073) | 2.96950055 |
| 134 | organic cation transport (GO:0015695) | 2.96390172 |
| 135 | vitamin transmembrane transport (GO:0035461) | 2.95723965 |
| 136 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.90487828 |
| 137 | glomerular epithelial cell development (GO:0072310) | 2.85905272 |
| 138 | endocrine pancreas development (GO:0031018) | 2.85303789 |
| 139 | epithelial cilium movement (GO:0003351) | 2.84603666 |
| 140 | fat-soluble vitamin catabolic process (GO:0042363) | 2.80852358 |
| 141 | vitamin catabolic process (GO:0009111) | 2.80852358 |
| 142 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.80192362 |
| 143 | organic hydroxy compound catabolic process (GO:1901616) | 2.79073894 |
| 144 | nitric oxide biosynthetic process (GO:0006809) | 2.77578266 |
| 145 | quaternary ammonium group transport (GO:0015697) | 2.76836946 |
| 146 | drug transport (GO:0015893) | 2.75856240 |
| 147 | androgen biosynthetic process (GO:0006702) | 2.74364224 |
| 148 | COPII vesicle coating (GO:0048208) | 2.64098836 |
| 149 | axoneme assembly (GO:0035082) | 2.61405824 |
| 150 | auditory receptor cell differentiation (GO:0042491) | 2.61015069 |
| 151 | xenobiotic catabolic process (GO:0042178) | 2.59749277 |
| 152 | artery smooth muscle contraction (GO:0014824) | 2.58756155 |
| 153 | detection of calcium ion (GO:0005513) | 2.55830541 |
| 154 | epithelial cell fate commitment (GO:0072148) | 2.55741524 |
| 155 | positive regulation of macroautophagy (GO:0016239) | 2.55100788 |
| 156 | renal absorption (GO:0070293) | 2.52381712 |
| 157 | positive regulation of actin filament depolymerization (GO:0030836) | 2.49957199 |
| 158 | * retinol metabolic process (GO:0042572) | 2.47127638 |
| 159 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.46458551 |
| 160 | tonic smooth muscle contraction (GO:0014820) | 2.46104452 |
| 161 | catecholamine transport (GO:0051937) | 2.45258698 |
| 162 | L-ascorbic acid metabolic process (GO:0019852) | 2.42345410 |
| 163 | * cellular hormone metabolic process (GO:0034754) | 2.42322440 |
| 164 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.41513004 |
| 165 | nephron tubule morphogenesis (GO:0072078) | 2.40438768 |
| 166 | nephron epithelium morphogenesis (GO:0072088) | 2.40438768 |
| 167 | glycerophospholipid catabolic process (GO:0046475) | 2.39967776 |
| 168 | glomerular basement membrane development (GO:0032836) | 2.39290450 |
| 169 | daunorubicin metabolic process (GO:0044597) | 10.8594224 |
| 170 | polyketide metabolic process (GO:0030638) | 10.8594224 |
| 171 | doxorubicin metabolic process (GO:0044598) | 10.8594224 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.37404099 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 6.96742280 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.19650496 |
| 4 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.92542062 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.77638607 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.86905119 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.81101544 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.02659538 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.62506215 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.09617541 |
| 11 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.15212134 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.4939970 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.90676936 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.88851519 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.85148887 |
| 16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.85143937 |
| 17 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.83058631 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.82764347 |
| 19 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.66179591 |
| 20 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.59423621 |
| 21 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.54340231 |
| 22 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.53109481 |
| 23 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.51766403 |
| 24 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.43625874 |
| 25 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.42926252 |
| 26 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.41870202 |
| 27 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.38102431 |
| 28 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.37485613 |
| 29 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.35262851 |
| 30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.34726295 |
| 31 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.33600346 |
| 32 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.32773927 |
| 33 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.32512296 |
| 34 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.28731619 |
| 35 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.19990298 |
| 36 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.18278078 |
| 37 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.17818934 |
| 38 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.16596731 |
| 39 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.15766726 |
| 40 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.15310350 |
| 41 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.15226843 |
| 42 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.14375549 |
| 43 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.14141212 |
| 44 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.10984571 |
| 45 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.10590511 |
| 46 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.10397386 |
| 47 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.10005530 |
| 48 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.09163214 |
| 49 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09062729 |
| 50 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.08833270 |
| 51 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.08119923 |
| 52 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.07647531 |
| 53 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.05531098 |
| 54 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.05237060 |
| 55 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.05184988 |
| 56 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.03757074 |
| 57 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03476055 |
| 58 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.02423323 |
| 59 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.01176642 |
| 60 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99896653 |
| 61 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.99824324 |
| 62 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.99518879 |
| 63 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.98730428 |
| 64 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98418760 |
| 65 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.98012343 |
| 66 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.96648061 |
| 67 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.96648061 |
| 68 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.95592272 |
| 69 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.95353843 |
| 70 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.95268181 |
| 71 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.95116111 |
| 72 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.95038465 |
| 73 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.94915948 |
| 74 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.94567203 |
| 75 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94343496 |
| 76 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.94096914 |
| 77 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.93665015 |
| 78 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.92938152 |
| 79 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.92136589 |
| 80 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.91158940 |
| 81 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.90883691 |
| 82 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90683103 |
| 83 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.90070267 |
| 84 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.89491472 |
| 85 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.88969458 |
| 86 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.88503934 |
| 87 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.88107979 |
| 88 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.88014702 |
| 89 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.88014702 |
| 90 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.86113399 |
| 91 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.80919737 |
| 92 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.73283247 |
| 93 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.71773542 |
| 94 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.71563470 |
| 95 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.71136554 |
| 96 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.70306475 |
| 97 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70304719 |
| 98 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.70145913 |
| 99 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.68297462 |
| 100 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.68015118 |
| 101 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.66749257 |
| 102 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.66738972 |
| 103 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.64424527 |
| 104 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.63079107 |
| 105 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.61934014 |
| 106 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.61472688 |
| 107 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.61325254 |
| 108 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.60982367 |
| 109 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.59535894 |
| 110 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.59220388 |
| 111 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.59214140 |
| 112 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.58895814 |
| 113 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.58078141 |
| 114 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.58005360 |
| 115 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.56335292 |
| 116 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.55673458 |
| 117 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.55206498 |
| 118 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.55062665 |
| 119 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.54921017 |
| 120 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.54448387 |
| 121 | CBP_21632823_ChIP-Seq_H3396_Human | 0.54301621 |
| 122 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.53769932 |
| 123 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.53124873 |
| 124 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.52815882 |
| 125 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52358353 |
| 126 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.52356805 |
| 127 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.52301000 |
| 128 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.50364164 |
| 129 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.50080900 |
| 130 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.49901777 |
| 131 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.48374292 |
| 132 | TP53_16413492_ChIP-PET_HCT116_Human | 0.47190915 |
| 133 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.47088108 |
| 134 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.46516394 |
| 135 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.46455225 |
| 136 | GATA1_19941826_ChIP-Seq_K562_Human | 0.46404533 |
| 137 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.45951931 |
| 138 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.45631950 |
| 139 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.45475366 |
| 140 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.45104799 |
| 141 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.44940639 |
| 142 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.44368364 |
| 143 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.44167707 |
| 144 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.44140839 |
| 145 | AR_20517297_ChIP-Seq_VCAP_Human | 0.43831558 |
| 146 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.43720183 |
| 147 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.42942833 |
| 148 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42918229 |
| 149 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.42657952 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0002139_abnormal_hepatobiliary_system | 8.24774512 |
| 2 | MP0005360_urolithiasis | 6.93120872 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.01870587 |
| 4 | MP0005365_abnormal_bile_salt | 5.85687813 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.40168665 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.80441632 |
| 7 | MP0000013_abnormal_adipose_tissue | 3.74596424 |
| 8 | MP0003252_abnormal_bile_duct | 3.65844832 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.54474673 |
| 10 | MP0005379_endocrine/exocrine_gland_phen | 3.08805450 |
| 11 | MP0005083_abnormal_biliary_tract | 3.08266132 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.79165458 |
| 13 | MP0009840_abnormal_foam_cell | 2.70454172 |
| 14 | MP0003195_calcinosis | 2.65869988 |
| 15 | MP0005332_abnormal_amino_acid | 2.51885264 |
| 16 | MP0001944_abnormal_pancreas_morphology | 2.42656254 |
| 17 | MP0005645_abnormal_hypothalamus_physiol | 2.19102152 |
| 18 | MP0003868_abnormal_feces_composition | 2.16582068 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.12675080 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 2.04932061 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 2.02892457 |
| 22 | MP0010386_abnormal_urinary_bladder | 1.99418253 |
| 23 | MP0000609_abnormal_liver_physiology | 1.98940645 |
| 24 | MP0004019_abnormal_vitamin_homeostasis | 1.95156295 |
| 25 | MP0004043_abnormal_pH_regulation | 1.85586543 |
| 26 | MP0004133_heterotaxia | 1.85209418 |
| 27 | MP0002693_abnormal_pancreas_physiology | 1.81838358 |
| 28 | MP0002822_catalepsy | 1.70744178 |
| 29 | MP0005319_abnormal_enzyme/_coenzyme | 1.70497074 |
| 30 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.70200668 |
| 31 | MP0004270_analgesia | 1.69144486 |
| 32 | MP0002163_abnormal_gland_morphology | 1.67736382 |
| 33 | MP0003283_abnormal_digestive_organ | 1.64481152 |
| 34 | MP0000003_abnormal_adipose_tissue | 1.51579895 |
| 35 | MP0001765_abnormal_ion_homeostasis | 1.46402013 |
| 36 | MP0001764_abnormal_homeostasis | 1.38498580 |
| 37 | MP0010678_abnormal_skin_adnexa | 1.29413720 |
| 38 | MP0001905_abnormal_dopamine_level | 1.26265327 |
| 39 | MP0005647_abnormal_sex_gland | 1.25945530 |
| 40 | MP0010352_gastrointestinal_tract_polyps | 1.23747141 |
| 41 | MP0009697_abnormal_copulation | 1.21351324 |
| 42 | MP0009643_abnormal_urine_homeostasis | 1.16812926 |
| 43 | MP0008775_abnormal_heart_ventricle | 1.16423748 |
| 44 | MP0003186_abnormal_redox_activity | 1.13193596 |
| 45 | MP0003172_abnormal_lysosome_physiology | 1.12367006 |
| 46 | MP0002909_abnormal_adrenal_gland | 1.12139855 |
| 47 | MP0009764_decreased_sensitivity_to | 1.11894945 |
| 48 | MP0000639_abnormal_adrenal_gland | 1.10437737 |
| 49 | MP0008438_abnormal_cutaneous_collagen | 1.07951473 |
| 50 | MP0005646_abnormal_pituitary_gland | 1.07760181 |
| 51 | MP0002254_reproductive_system_inflammat | 1.07757996 |
| 52 | MP0003705_abnormal_hypodermis_morpholog | 1.07347705 |
| 53 | MP0005535_abnormal_body_temperature | 1.05750346 |
| 54 | MP0006072_abnormal_retinal_apoptosis | 1.05528813 |
| 55 | MP0005058_abnormal_lysosome_morphology | 1.03575786 |
| 56 | MP0003011_delayed_dark_adaptation | 1.02064452 |
| 57 | MP0003656_abnormal_erythrocyte_physiolo | 1.01884976 |
| 58 | MP0010368_abnormal_lymphatic_system | 1.00899689 |
| 59 | MP0000598_abnormal_liver_morphology | 1.00144446 |
| 60 | MP0000604_amyloidosis | 0.99270159 |
| 61 | MP0001984_abnormal_olfaction | 0.97852887 |
| 62 | MP0008872_abnormal_physiological_respon | 0.95257022 |
| 63 | MP0003879_abnormal_hair_cell | 0.94201785 |
| 64 | MP0004130_abnormal_muscle_cell | 0.93016239 |
| 65 | MP0009046_muscle_twitch | 0.92375010 |
| 66 | MP0005376_homeostasis/metabolism_phenot | 0.91385791 |
| 67 | MP0003880_abnormal_central_pattern | 0.90902643 |
| 68 | MP0005636_abnormal_mineral_homeostasis | 0.90455865 |
| 69 | MP0000383_abnormal_hair_follicle | 0.89488537 |
| 70 | MP0001501_abnormal_sleep_pattern | 0.88429461 |
| 71 | MP0003690_abnormal_glial_cell | 0.84750739 |
| 72 | MP0005408_hypopigmentation | 0.83387605 |
| 73 | MP0010234_abnormal_vibrissa_follicle | 0.81891667 |
| 74 | MP0006276_abnormal_autonomic_nervous | 0.81755375 |
| 75 | MP0001661_extended_life_span | 0.81329405 |
| 76 | MP0004782_abnormal_surfactant_physiolog | 0.79875177 |
| 77 | MP0000613_abnormal_salivary_gland | 0.79850791 |
| 78 | MP0009763_increased_sensitivity_to | 0.79760602 |
| 79 | MP0006036_abnormal_mitochondrial_physio | 0.79261149 |
| 80 | MP0000462_abnormal_digestive_system | 0.78126360 |
| 81 | MP0005451_abnormal_body_composition | 0.76759206 |
| 82 | MP0003329_amyloid_beta_deposits | 0.76668696 |
| 83 | MP0004147_increased_porphyrin_level | 0.76491864 |
| 84 | MP0009642_abnormal_blood_homeostasis | 0.76365427 |
| 85 | MP0003633_abnormal_nervous_system | 0.72630698 |
| 86 | MP0005266_abnormal_metabolism | 0.72394769 |
| 87 | MP0005334_abnormal_fat_pad | 0.71974618 |
| 88 | MP0002078_abnormal_glucose_homeostasis | 0.69902728 |
| 89 | MP0009765_abnormal_xenobiotic_induced | 0.69751888 |
| 90 | MP0002896_abnormal_bone_mineralization | 0.68914388 |
| 91 | MP0002277_abnormal_respiratory_mucosa | 0.68523803 |
| 92 | MP0008469_abnormal_protein_level | 0.68234188 |
| 93 | MP0005220_abnormal_exocrine_pancreas | 0.68137756 |
| 94 | MP0002090_abnormal_vision | 0.66056362 |
| 95 | MP0004085_abnormal_heartbeat | 0.66027583 |
| 96 | MP0003566_abnormal_cell_adhesion | 0.65669391 |
| 97 | MP0001756_abnormal_urination | 0.65209965 |
| 98 | MP0003122_maternal_imprinting | 0.62438521 |
| 99 | MP0008874_decreased_physiological_sensi | 0.62403365 |
| 100 | MP0004215_abnormal_myocardial_fiber | 0.62385778 |
| 101 | MP0002876_abnormal_thyroid_physiology | 0.62049550 |
| 102 | MP0005551_abnormal_eye_electrophysiolog | 0.62023383 |
| 103 | MP0002160_abnormal_reproductive_system | 0.61378476 |
| 104 | MP0002837_dystrophic_cardiac_calcinosis | 0.61169306 |
| 105 | MP0004883_abnormal_blood_vessel | 0.61029082 |
| 106 | MP0006035_abnormal_mitochondrial_morpho | 0.60506824 |
| 107 | MP0003091_abnormal_cell_migration | 0.60263514 |
| 108 | MP0005165_increased_susceptibility_to | 0.59730411 |
| 109 | MP0004272_abnormal_basement_membrane | 0.59524116 |
| 110 | MP0005167_abnormal_blood-brain_barrier | 0.58988414 |
| 111 | MP0002971_abnormal_brown_adipose | 0.58745039 |
| 112 | MP0001881_abnormal_mammary_gland | 0.58432428 |
| 113 | MP0005084_abnormal_gallbladder_morpholo | 0.58078309 |
| 114 | MP0005389_reproductive_system_phenotype | 0.56698981 |
| 115 | MP0005164_abnormal_response_to | 0.56569802 |
| 116 | MP0005670_abnormal_white_adipose | 0.55484191 |
| 117 | MP0001529_abnormal_vocalization | 0.53827989 |
| 118 | MP0009384_cardiac_valve_regurgitation | 0.53362789 |
| 119 | MP0006054_spinal_hemorrhage | 0.52791753 |
| 120 | MP0005375_adipose_tissue_phenotype | 0.52561062 |
| 121 | MP0005409_darkened_coat_color | 0.52312849 |
| 122 | MP0008873_increased_physiological_sensi | 0.51634967 |
| 123 | MP0001270_distended_abdomen | 0.51113476 |
| 124 | MP0003638_abnormal_response/metabolism_ | 0.50862670 |
| 125 | MP0002168_other_aberrant_phenotype | 0.50228983 |
| 126 | MP0005448_abnormal_energy_balance | 0.48594450 |
| 127 | MP0003724_increased_susceptibility_to | 0.48541776 |
| 128 | MP0000538_abnormal_urinary_bladder | 0.47760331 |
| 129 | MP0003953_abnormal_hormone_level | 0.46493645 |
| 130 | MP0005395_other_phenotype | 0.45558778 |
| 131 | MP0000230_abnormal_systemic_arterial | 0.43458553 |
| 132 | MP0002136_abnormal_kidney_physiology | 0.41327370 |
| 133 | MP0009053_abnormal_anal_canal | 0.40588647 |
| 134 | MP0000249_abnormal_blood_vessel | 0.40564538 |
| 135 | MP0002295_abnormal_pulmonary_circulatio | 0.40078445 |
| 136 | MP0001664_abnormal_digestion | 0.38144827 |
| 137 | MP0009780_abnormal_chondrocyte_physiolo | 0.37678686 |
| 138 | MP0005166_decreased_susceptibility_to | 0.37430952 |
| 139 | MP0005464_abnormal_platelet_physiology | 0.37387180 |
| 140 | MP0002332_abnormal_exercise_endurance | 0.36705258 |
| 141 | MP0003632_abnormal_nervous_system | 0.36493991 |
| 142 | MP0005187_abnormal_penis_morphology | 0.35558226 |
| 143 | MP0002928_abnormal_bile_duct | 0.34673760 |
| 144 | MP0004924_abnormal_behavior | 0.32344886 |
| 145 | MP0005386_behavior/neurological_phenoty | 0.32344886 |
| 146 | MP0002796_impaired_skin_barrier | 0.31752830 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.15628890 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.83427237 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.72391920 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 6.13403562 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.09621093 |
| 6 | Xanthomatosis (HP:0000991) | 5.79700200 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.70957761 |
| 8 | Complement deficiency (HP:0004431) | 5.36058719 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.15386888 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.48054349 |
| 11 | Hyperammonemia (HP:0001987) | 4.25847030 |
| 12 | Joint hemorrhage (HP:0005261) | 4.21014076 |
| 13 | Epidermoid cyst (HP:0200040) | 4.11861549 |
| 14 | Abnormal respiratory epithelium morphology (HP:0012253) | 4.11463479 |
| 15 | Abnormal respiratory motile cilium morphology (HP:0005938) | 4.11463479 |
| 16 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.09917703 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.07666203 |
| 18 | Hyperglycinemia (HP:0002154) | 4.05706471 |
| 19 | Abnormality of the common coagulation pathway (HP:0010990) | 3.99413178 |
| 20 | Fat malabsorption (HP:0002630) | 3.95516635 |
| 21 | Ketosis (HP:0001946) | 3.94030590 |
| 22 | Limb dystonia (HP:0002451) | 3.91577169 |
| 23 | Abnormal ciliary motility (HP:0012262) | 3.87772275 |
| 24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.78515932 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 3.77867939 |
| 26 | Abnormality of complement system (HP:0005339) | 3.77812090 |
| 27 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.75576698 |
| 28 | Absent/shortened dynein arms (HP:0200106) | 3.75576698 |
| 29 | Rhinitis (HP:0012384) | 3.75293015 |
| 30 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.72071215 |
| 31 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.70524325 |
| 32 | Abnormal sex determination (HP:0012244) | 3.62912748 |
| 33 | Sex reversal (HP:0012245) | 3.62912748 |
| 34 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.59377519 |
| 35 | Abnormality of methionine metabolism (HP:0010901) | 3.58844379 |
| 36 | Abnormality of glycine metabolism (HP:0010895) | 3.54926558 |
| 37 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.54926558 |
| 38 | Hyperglycinuria (HP:0003108) | 3.53899364 |
| 39 | Abnormality of the intrinsic pathway (HP:0010989) | 3.44291915 |
| 40 | Hypoglycemic coma (HP:0001325) | 3.41382624 |
| 41 | Hypercholesterolemia (HP:0003124) | 3.32159104 |
| 42 | Conjugated hyperbilirubinemia (HP:0002908) | 3.31416965 |
| 43 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.17010680 |
| 44 | Proximal tubulopathy (HP:0000114) | 3.04764443 |
| 45 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.01343186 |
| 46 | Increased CSF protein (HP:0002922) | 3.01247338 |
| 47 | Steatorrhea (HP:0002570) | 2.97523118 |
| 48 | Hyperglycemia (HP:0003074) | 2.96118635 |
| 49 | Hyperbilirubinemia (HP:0002904) | 2.94194456 |
| 50 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.93305260 |
| 51 | Mucopolysacchariduria (HP:0008155) | 2.93305260 |
| 52 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.92984826 |
| 53 | Skin nodule (HP:0200036) | 2.91167552 |
| 54 | Ketoacidosis (HP:0001993) | 2.86772716 |
| 55 | Delayed CNS myelination (HP:0002188) | 2.86149090 |
| 56 | Tubular atrophy (HP:0000092) | 2.83397497 |
| 57 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.80644465 |
| 58 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.80644465 |
| 59 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.80644465 |
| 60 | Glycosuria (HP:0003076) | 2.78984825 |
| 61 | Abnormality of urine glucose concentration (HP:0011016) | 2.78984825 |
| 62 | Hypoalbuminemia (HP:0003073) | 2.77825073 |
| 63 | Abnormal albumin level (HP:0012116) | 2.77825073 |
| 64 | Nuclear cataract (HP:0100018) | 2.77436643 |
| 65 | Spontaneous abortion (HP:0005268) | 2.73747743 |
| 66 | Hepatocellular carcinoma (HP:0001402) | 2.72833741 |
| 67 | Gout (HP:0001997) | 2.71610653 |
| 68 | Abnormality of nucleobase metabolism (HP:0010932) | 2.70095122 |
| 69 | Potter facies (HP:0002009) | 2.65135688 |
| 70 | Facial shape deformation (HP:0011334) | 2.65135688 |
| 71 | Abnormality of serum amino acid levels (HP:0003112) | 2.63617181 |
| 72 | Metabolic acidosis (HP:0001942) | 2.62791852 |
| 73 | Bronchiectasis (HP:0002110) | 2.62155052 |
| 74 | Myocardial infarction (HP:0001658) | 2.60386964 |
| 75 | Abnormality of purine metabolism (HP:0004352) | 2.58650270 |
| 76 | Vascular calcification (HP:0004934) | 2.57756104 |
| 77 | Cerebral hemorrhage (HP:0001342) | 2.53857694 |
| 78 | Mitral stenosis (HP:0001718) | 2.49274013 |
| 79 | Abnormal gallbladder physiology (HP:0012438) | 2.48736681 |
| 80 | Cholecystitis (HP:0001082) | 2.48736681 |
| 81 | Amyloidosis (HP:0011034) | 2.46310549 |
| 82 | Acanthocytosis (HP:0001927) | 2.45875867 |
| 83 | Systemic lupus erythematosus (HP:0002725) | 2.45187829 |
| 84 | Lethargy (HP:0001254) | 2.40765588 |
| 85 | Abnormal gallbladder morphology (HP:0012437) | 2.40120948 |
| 86 | Irritability (HP:0000737) | 2.39613070 |
| 87 | Cholelithiasis (HP:0001081) | 2.38551740 |
| 88 | Hypochromic microcytic anemia (HP:0004840) | 2.38336412 |
| 89 | Spastic diplegia (HP:0001264) | 2.37244321 |
| 90 | Glomerulonephritis (HP:0000099) | 2.37194369 |
| 91 | Esophageal varix (HP:0002040) | 2.34836800 |
| 92 | Cerebral edema (HP:0002181) | 2.34324937 |
| 93 | Neonatal onset (HP:0003623) | 2.32471613 |
| 94 | Cardiovascular calcification (HP:0011915) | 2.32099212 |
| 95 | Fetal akinesia sequence (HP:0001989) | 2.31012281 |
| 96 | Zonular cataract (HP:0010920) | 2.30783182 |
| 97 | Malnutrition (HP:0004395) | 2.30523362 |
| 98 | Arthropathy (HP:0003040) | 2.29967205 |
| 99 | Occipital encephalocele (HP:0002085) | 2.28793142 |
| 100 | Abnormal pancreas size (HP:0012094) | 2.25839748 |
| 101 | Abnormal pupillary function (HP:0007686) | 2.25668922 |
| 102 | Progressive neurologic deterioration (HP:0002344) | 2.25662204 |
| 103 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.25544718 |
| 104 | Dicarboxylic aciduria (HP:0003215) | 2.25544718 |
| 105 | Focal segmental glomerulosclerosis (HP:0000097) | 2.24526649 |
| 106 | Sensorimotor neuropathy (HP:0007141) | 2.22351742 |
| 107 | Hypokinesia (HP:0002375) | 2.20885551 |
| 108 | Prolonged neonatal jaundice (HP:0006579) | 2.20756710 |
| 109 | Hypothermia (HP:0002045) | 2.19927539 |
| 110 | Abnormality of vitamin B metabolism (HP:0004340) | 2.19609945 |
| 111 | Polycythemia (HP:0001901) | 2.14869246 |
| 112 | Congenital malformation of the right heart (HP:0011723) | 2.13622374 |
| 113 | Double outlet right ventricle (HP:0001719) | 2.13622374 |
| 114 | Unilateral renal agenesis (HP:0000122) | 2.13102896 |
| 115 | Orthostatic hypotension (HP:0001278) | 2.12324253 |
| 116 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.11067591 |
| 117 | Vacuolated lymphocytes (HP:0001922) | 2.11019526 |
| 118 | Hypoglycemic seizures (HP:0002173) | 2.10785490 |
| 119 | Testicular neoplasm (HP:0010788) | 2.09977899 |
| 120 | Abnormality of the gallbladder (HP:0005264) | 2.09797604 |
| 121 | Diminished movement (HP:0002374) | 2.08271712 |
| 122 | Stage 5 chronic kidney disease (HP:0003774) | 2.05739671 |
| 123 | Limb hypertonia (HP:0002509) | 2.03556592 |
| 124 | Hemorrhage of the eye (HP:0011885) | 2.02515479 |
| 125 | Cardiomegaly (HP:0001640) | 2.02409268 |
| 126 | Abnormal glucose tolerance (HP:0001952) | 2.02223663 |
| 127 | Enlarged penis (HP:0000040) | 1.99564453 |
| 128 | Chronic bronchitis (HP:0004469) | 1.99073158 |
| 129 | Mesangial abnormality (HP:0001966) | 1.98711413 |
| 130 | Generalized aminoaciduria (HP:0002909) | 1.98270227 |
| 131 | Brushfield spots (HP:0001088) | 1.97645572 |
| 132 | Nephritis (HP:0000123) | 1.97167125 |
| 133 | Vomiting (HP:0002013) | 1.96616025 |
| 134 | Testicular atrophy (HP:0000029) | 1.96145370 |
| 135 | Abnormality of renal excretion (HP:0011036) | 1.96055335 |
| 136 | Glucose intolerance (HP:0000833) | 1.94249063 |
| 137 | Menorrhagia (HP:0000132) | 1.93713719 |
| 138 | Late onset (HP:0003584) | 1.92801704 |
| 139 | Abnormal cartilage morphology (HP:0002763) | 1.91635267 |
| 140 | Large for gestational age (HP:0001520) | 1.91417390 |
| 141 | Hyperphosphaturia (HP:0003109) | 1.88879223 |
| 142 | Abnormality of vitamin metabolism (HP:0100508) | 1.88749699 |
| 143 | Peritonitis (HP:0002586) | 1.88314166 |
| 144 | Infertility (HP:0000789) | 1.86572785 |
| 145 | Thrombophlebitis (HP:0004418) | 1.85127105 |
| 146 | Congenital sensorineural hearing impairment (HP:0008527) | 1.84739397 |
| 147 | Glomerulosclerosis (HP:0000096) | 1.84476760 |
| 148 | Pancreatic fibrosis (HP:0100732) | 1.84305720 |
| 149 | Abnormal urine output (HP:0012590) | 1.82548165 |
| 150 | Pancreatitis (HP:0001733) | 1.82099296 |
| 151 | Postural tremor (HP:0002174) | 1.79146776 |
| 152 | Rickets (HP:0002748) | 1.78809783 |
| 153 | Nasal polyposis (HP:0100582) | 1.78081097 |
| 154 | Dysostosis multiplex (HP:0000943) | 1.77874250 |
| 155 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.77855620 |
| 156 | Hypoplasia of the uterus (HP:0000013) | 1.77506346 |
| 157 | Akinesia (HP:0002304) | 1.77363363 |
| 158 | Stroke (HP:0001297) | 1.77258636 |
| 159 | Back pain (HP:0003418) | 1.77084576 |
| 160 | Nephronophthisis (HP:0000090) | 1.76851151 |
| 161 | Status epilepticus (HP:0002133) | 1.76224698 |
| 162 | Abnormality of proline metabolism (HP:0010907) | 1.76076926 |
| 163 | Hydroxyprolinuria (HP:0003080) | 1.76076926 |
| 164 | Polyuria (HP:0000103) | 1.76009560 |
| 165 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.75907862 |
| 166 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.75907862 |
| 167 | Abnormality of glycolipid metabolism (HP:0010969) | 1.75907862 |
| 168 | Poikilocytosis (HP:0004447) | 1.75810979 |
| 169 | Hypotension (HP:0002615) | 1.75112899 |
| 170 | Enlarged kidneys (HP:0000105) | 1.74668794 |
| 171 | Male infertility (HP:0003251) | 1.74146052 |
| 172 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.73439856 |
| 173 | Pheochromocytoma (HP:0002666) | 1.72545913 |
| 174 | Abnormality of dentin (HP:0010299) | 1.71676453 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.14800708 |
| 2 | TRPM7 | 3.88671830 |
| 3 | MST4 | 3.52880996 |
| 4 | SIK1 | 3.52878396 |
| 5 | MAP2K4 | 3.45017412 |
| 6 | ERN1 | 3.36883521 |
| 7 | FGFR4 | 3.26130768 |
| 8 | PHKG2 | 2.53699820 |
| 9 | PHKG1 | 2.53699820 |
| 10 | TESK1 | 2.34071143 |
| 11 | ERBB4 | 2.33612207 |
| 12 | MAP3K12 | 2.30119674 |
| 13 | CSNK1G3 | 2.22115021 |
| 14 | TRIB3 | 2.20665672 |
| 15 | LIMK1 | 2.20544362 |
| 16 | NTRK3 | 2.15977604 |
| 17 | MST1R | 2.09509241 |
| 18 | IRAK3 | 2.04730218 |
| 19 | CSNK1G2 | 2.02277317 |
| 20 | ERBB3 | 2.01172971 |
| 21 | CSNK1G1 | 1.98417153 |
| 22 | TAOK3 | 1.89080928 |
| 23 | MAPKAPK5 | 1.86789097 |
| 24 | PKN2 | 1.84026355 |
| 25 | EPHA2 | 1.80426788 |
| 26 | MAPKAPK3 | 1.79746723 |
| 27 | TIE1 | 1.75649961 |
| 28 | INSRR | 1.74208859 |
| 29 | MAP3K4 | 1.69056036 |
| 30 | PTK6 | 1.68537384 |
| 31 | RET | 1.66317978 |
| 32 | STK3 | 1.64775636 |
| 33 | FRK | 1.56534874 |
| 34 | RIPK1 | 1.54521871 |
| 35 | TYK2 | 1.50446654 |
| 36 | FGFR2 | 1.48620938 |
| 37 | TTN | 1.47321621 |
| 38 | PTK2 | 1.42779869 |
| 39 | MAP4K2 | 1.41172711 |
| 40 | DAPK2 | 1.40593747 |
| 41 | PRKCE | 1.39647216 |
| 42 | MYLK | 1.38647366 |
| 43 | EPHA3 | 1.37600830 |
| 44 | LATS1 | 1.36507447 |
| 45 | PIK3CG | 1.35356345 |
| 46 | GRK6 | 1.34986816 |
| 47 | ACVR1B | 1.34222227 |
| 48 | PRKG2 | 1.26875563 |
| 49 | WNK3 | 1.23996834 |
| 50 | CAMK2D | 1.21274136 |
| 51 | PINK1 | 1.19199006 |
| 52 | ADRBK2 | 1.16796088 |
| 53 | MAP2K7 | 1.15795602 |
| 54 | DDR2 | 1.12426454 |
| 55 | MAP3K9 | 1.10416641 |
| 56 | ABL2 | 1.09948324 |
| 57 | FER | 1.08212202 |
| 58 | STK24 | 1.05946206 |
| 59 | GRK5 | 1.04525726 |
| 60 | STK4 | 1.03987048 |
| 61 | TGFBR2 | 1.00549840 |
| 62 | KSR2 | 0.99806770 |
| 63 | CAMK1G | 0.97183210 |
| 64 | MAP3K11 | 0.94812045 |
| 65 | MAPK11 | 0.91858918 |
| 66 | EPHA4 | 0.90518429 |
| 67 | PRKCI | 0.88481030 |
| 68 | PDK3 | 0.87759636 |
| 69 | PDK4 | 0.87759636 |
| 70 | CAMK2G | 0.87243891 |
| 71 | MAP3K7 | 0.86303143 |
| 72 | FLT3 | 0.85862442 |
| 73 | PRKCZ | 0.84752257 |
| 74 | JAK2 | 0.83981151 |
| 75 | LMTK2 | 0.81172916 |
| 76 | LATS2 | 0.78623132 |
| 77 | CAMK1D | 0.77804760 |
| 78 | NEK9 | 0.77438151 |
| 79 | PDPK1 | 0.76597409 |
| 80 | WNK4 | 0.75459651 |
| 81 | CASK | 0.75111065 |
| 82 | MAP3K13 | 0.74869321 |
| 83 | BMPR2 | 0.74793148 |
| 84 | MAP3K2 | 0.74124782 |
| 85 | PRKAA2 | 0.73541321 |
| 86 | CDC42BPA | 0.73498118 |
| 87 | ERBB2 | 0.73324815 |
| 88 | MAP2K1 | 0.72181432 |
| 89 | NLK | 0.72139426 |
| 90 | TYRO3 | 0.69881751 |
| 91 | NTRK1 | 0.67871839 |
| 92 | PIK3CA | 0.66845508 |
| 93 | MAP2K3 | 0.66769023 |
| 94 | KDR | 0.66322362 |
| 95 | PRKACG | 0.64524790 |
| 96 | PNCK | 0.63958872 |
| 97 | OXSR1 | 0.63664584 |
| 98 | JAK1 | 0.63416709 |
| 99 | MET | 0.63078843 |
| 100 | PDGFRA | 0.62554313 |
| 101 | PTK2B | 0.62229179 |
| 102 | PAK3 | 0.61892296 |
| 103 | RPS6KB2 | 0.60780882 |
| 104 | MAP3K1 | 0.60379401 |
| 105 | EPHB1 | 0.60305922 |
| 106 | ROCK1 | 0.58820174 |
| 107 | GSK3A | 0.57285987 |
| 108 | IRAK1 | 0.57181091 |
| 109 | MAPK4 | 0.56880780 |
| 110 | SGK3 | 0.56738296 |
| 111 | ARAF | 0.56664002 |
| 112 | MAP2K6 | 0.56146213 |
| 113 | STK38 | 0.55673534 |
| 114 | CAMK2A | 0.54468644 |
| 115 | IGF1R | 0.54423824 |
| 116 | PDK1 | 0.49411446 |
| 117 | CSK | 0.49232574 |
| 118 | GRK1 | 0.48566022 |
| 119 | MAPK12 | 0.48172778 |
| 120 | ICK | 0.48069714 |
| 121 | TBK1 | 0.47426017 |
| 122 | AKT3 | 0.45355810 |
| 123 | MAP3K3 | 0.45352905 |
| 124 | EIF2AK1 | 0.45174801 |
| 125 | CDK6 | 0.44723414 |
| 126 | HIPK2 | 0.44512563 |
| 127 | PAK4 | 0.43880587 |
| 128 | MUSK | 0.42628708 |
| 129 | PRKCG | 0.42180097 |
| 130 | PRKAA1 | 0.42159928 |
| 131 | SGK494 | 0.40808419 |
| 132 | SGK223 | 0.40808419 |
| 133 | EGFR | 0.40451099 |
| 134 | CAMK2B | 0.40231454 |
| 135 | SGK2 | 0.40139127 |
| 136 | FGFR3 | 0.39637050 |
| 137 | ILK | 0.38598667 |
| 138 | STK39 | 0.38342074 |
| 139 | CAMKK2 | 0.37881459 |
| 140 | MINK1 | 0.37814126 |
| 141 | EPHB2 | 0.37412676 |
| 142 | DAPK1 | 0.37118482 |
| 143 | MKNK2 | 0.36226375 |
| 144 | MAPK15 | 0.35233330 |
| 145 | STK38L | 0.34572979 |
| 146 | ROCK2 | 0.34349160 |
| 147 | PRKCQ | 0.33996773 |
| 148 | CHUK | 0.33837283 |
| 149 | PRKG1 | 0.31743973 |
| 150 | BMX | 0.30169139 |
| 151 | DAPK3 | 0.27977077 |
| 152 | PRKACA | 0.27575648 |
| 153 | PRKCA | 0.26815360 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.20671013 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.64043354 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.17308801 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.11171381 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.83425054 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.83030841 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.80942067 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.59583380 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.53904854 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.45544112 |
| 11 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.37374114 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.30774042 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 2.26727439 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.18870014 |
| 15 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.17716008 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.11013387 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.10546366 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.08109623 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.06060421 |
| 20 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.05587770 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.95969977 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.91703638 |
| 23 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.89712892 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.89556236 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87595880 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.67225891 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.66703039 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.66191174 |
| 29 | * Retinol metabolism_Homo sapiens_hsa00830 | 1.61400086 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.60734011 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.56612546 |
| 32 | Bile secretion_Homo sapiens_hsa04976 | 1.55594809 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.51039781 |
| 34 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.50717575 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.45836760 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.44918356 |
| 37 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.44550508 |
| 38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.43921952 |
| 39 | Other glycan degradation_Homo sapiens_hsa00511 | 1.41179720 |
| 40 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.40221598 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.39506884 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.37003821 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.35968168 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.35389077 |
| 45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22165939 |
| 46 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.20216069 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16177729 |
| 48 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.15914256 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11211618 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 1.09806358 |
| 51 | Insulin secretion_Homo sapiens_hsa04911 | 1.09702614 |
| 52 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.04964565 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.04675787 |
| 54 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.00370617 |
| 55 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.94551872 |
| 56 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.91995987 |
| 57 | Protein export_Homo sapiens_hsa03060 | 0.91704879 |
| 58 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.87876220 |
| 59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.87331107 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.86503107 |
| 61 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.84600714 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.80544847 |
| 63 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.80386353 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.79808250 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.77317275 |
| 66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.77226287 |
| 67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75071315 |
| 68 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.73807646 |
| 69 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.72881345 |
| 70 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.72612297 |
| 71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.67290427 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66690042 |
| 73 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.65914766 |
| 74 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.65548942 |
| 75 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.64605216 |
| 76 | Lysine degradation_Homo sapiens_hsa00310 | 0.64406504 |
| 77 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.63784867 |
| 78 | Sulfur relay system_Homo sapiens_hsa04122 | 0.62126871 |
| 79 | Lysosome_Homo sapiens_hsa04142 | 0.56686458 |
| 80 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.53425399 |
| 81 | Cocaine addiction_Homo sapiens_hsa05030 | 0.51682611 |
| 82 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.51245198 |
| 83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.48559733 |
| 84 | Circadian rhythm_Homo sapiens_hsa04710 | 0.46234566 |
| 85 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.41662072 |
| 86 | Prion diseases_Homo sapiens_hsa05020 | 0.38366661 |
| 87 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.37034949 |
| 88 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.35877122 |
| 89 | Tight junction_Homo sapiens_hsa04530 | 0.35104978 |
| 90 | Renin secretion_Homo sapiens_hsa04924 | 0.33106899 |
| 91 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.30716138 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26559478 |
| 93 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.26086857 |
| 94 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.26083953 |
| 95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.22763499 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.22498950 |
| 97 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.22268460 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19841063 |
| 99 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.19246210 |
| 100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.17637409 |
| 101 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.16840364 |
| 102 | Galactose metabolism_Homo sapiens_hsa00052 | 0.16824473 |
| 103 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.16241255 |
| 104 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.15650929 |
| 105 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.13827467 |
| 106 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.09414072 |
| 107 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.08149781 |
| 108 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.06059983 |
| 109 | Parkinsons disease_Homo sapiens_hsa05012 | 0.05314793 |
| 110 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.05124823 |
| 111 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.03678843 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01363573 |
| 113 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.00915871 |
| 114 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1601465 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1545562 |
| 116 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | -0.1544030 |
| 117 | Mineral absorption_Homo sapiens_hsa04978 | -0.1505281 |
| 118 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | -0.1451610 |
| 119 | Dopaminergic synapse_Homo sapiens_hsa04728 | -0.1236881 |
| 120 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.1125834 |
| 121 | Amoebiasis_Homo sapiens_hsa05146 | -0.0977663 |
| 122 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0884014 |
| 123 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0851253 |
| 124 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0787395 |
| 125 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0524750 |
| 126 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0506547 |
| 127 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0076792 |

